Literature DB >> 24090915

Synthesis of new andrographolide derivatives and evaluation of their antidyslipidemic, LDL-oxidation and antioxidant activity.

Sukanya Pandeti1, Ravi Sonkar, Astha Shukla, Gitika Bhatia, Narender Tadigoppula.   

Abstract

Andrographis paniculata, native to Taiwan, Mainland China and India, is a medicinal herb, which possesses various biological activities including anti-atherosclerosis. Andrographolide (1) has been identified as one of the active constituents against atherosclerosis. In continuation of our drug discovery program we synthesized few novel derivatives of 1 to improve their antidyslipidemic, LDL-oxidation and antioxidant activity. The tosylated derivative 7 has been turned out to be more potent than the parent compound and comparable activity with marketed antidyslipidemic drugs.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Andographis paniculata; Andrographolide derivatives; Anti oxidant activity; Antidyslipidemic activity; LDL oxidation; LPL activity

Mesh:

Substances:

Year:  2013        PMID: 24090915     DOI: 10.1016/j.ejmech.2013.09.002

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  4 in total

1.  Anti-cancer activity of heteroaromatic acetals of andrographolide and its isomers.

Authors:  Nitesh Tamang; Christopher Andrews; Sai Kiran Mavileti; Srinivas Nanduri; Nageswara Rao Golakoti; Balasubramanyam Karanam
Journal:  New J Chem       Date:  2022-04-22       Impact factor: 3.925

Review 2.  Chinese Herbal Compounds for the Prevention and Treatment of Atherosclerosis: Experimental Evidence and Mechanisms.

Authors:  Qing Liu; Jianping Li; Adam Hartstone-Rose; Jing Wang; Jiqiang Li; Joseph S Janicki; Daping Fan
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-18       Impact factor: 2.629

3.  In vitro Metabolism of Sodium 9-dehydro-17-hydro-andrographolide-19-yl Sulfate in Rat Liver S9 by Liquid Chromatography-Mass Spectrometry Method.

Authors:  Dongkun Zheng; Jun Shao; Weikang Chen; Yuehua Luo
Journal:  Pharmacogn Mag       Date:  2016-05-11       Impact factor: 1.085

Review 4.  Andrographolide, a New Hope in the Prevention and Treatment of Metabolic Syndrome.

Authors:  Muhammad T Islam
Journal:  Front Pharmacol       Date:  2017-08-23       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.